Management of antidepressant-induced bruxism

Management of antidepressant-induced bruxism

Saved in:

Bibliographic Details
Main Authors:	Hayley Cliatt, PharmD, Andrew M. Williams, PharmD, BCPP, Jessa Koch, PharmD, BCPP
Format:	Article
Language:	English
Published:	American Association of Psychiatric Pharmacists 2025-06-01
Series:	Mental Health Clinician
Subjects:	ssri snri bruxism buspirone
Online Access:	https://theijpt.org/doi/pdf/10.9740/mhc.2025.06.147
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Unveiling the Anti-Inflammatory Effects of Antidepressants: A Systematic Review of Human Studies over the Last Decade
by: Layla Bleibel, et al.
Published: (2025-06-01)

The Pharmacology of Anxiolytics
by: Kim Outhoff
Published: (2010-04-01)

Impact of psychiatric pharmacist-led ambulatory alcohol withdrawal management
by: Maxwell Lamb, PharmD, BCPS, et al.
Published: (2025-06-01)

Community pharmacy attitudes and behaviors following a buprenorphine best practices dissemination
by: Winter Roth, PharmD, BCPP, et al.
Published: (2025-04-01)

Implementation of mMINDS monitoring for alcohol withdrawal at an inpatient academic psychiatric facility
by: Leah A. Surbaugh, PharmD, BCPP, et al.
Published: (2025-08-01)

Managing ciprofloxacin-clozapine interaction with immunoassay-based monitoring: A case report
by: Kristin Waters, PharmD, BCPS, BCPP, et al.
Published: (2025-06-01)

Trazodone versus doxepin as a pharmacologic sleep aid in psychiatric inpatients: A retrospective cohort study
by: Kevin Chen, PharmD, et al.
Published: (2025-04-01)

Use of psychostimulants in the management of treatment-resistant major depressive disorder
by: Sara L. Pucci, PharmD, BCPP
Published: (2025-08-01)

Association of SSRI and SNRI use with incidence of cardiovascular events in veterans with giant cell arteritis and polymyalgia rheumatica
by: Tianyu Zhang, et al.
Published: (2025-04-01)

Psychotropic Drugs in Dermatology Part 1: Anti-depressants and Mood Stabilisers
by: Varsha L. Kenkare, et al.
Published: (2025-01-01)

Evaluation of burnout among Board-Certified Psychiatric Pharmacists in the United States
by: Samantha Catanzano, PharmD, BCPP, et al.
Published: (2025-06-01)

Evaluation of workload among Board-Certified Psychiatric Pharmacists in the United States
by: Kelly C. Lee, PharmD, MAS, BCPP, FCCP, FASHP, et al.
Published: (2025-06-01)

Suicide risk identification and mitigation in patients with chronic pain prescribed opioid medication
by: Dana L. Chiulli, PharmD, BCPP
Published: (2024-12-01)

Re: Hernandez Bustamante et al. “Pharmacist administration of long-acting injectable medications for substance use disorders”
by: Jerry McKee, PharmD, MS, BCPP, et al.
Published: (2025-08-01)

A primary care psychiatric pharmacist clinic for addressing hypertension and mental health disparities in black patients
by: Stephanie L. Hsia, PharmD, BCPP, MAEd, et al.
Published: (2025-08-01)

Age-Dependent Analysis of Suicidal Ideation, Suicide Attempts, and Suicides Associated with SSRI and SNRI Drugs Based on Pharmacovigilance Data
by: Daria Schetz, et al.
Published: (2024-12-01)

Review of acamprosate pharmacokinetics and dosing strategies
by: Lauren Steil, PharmD, et al.
Published: (2025-04-01)

A potential case of refeeding syndrome in a patient with severe mental illness
by: Amber R. Douglass, PharmD, BCPS, BCPP, FAAPP, et al.
Published: (2025-08-01)

Clozapine plasma level toxicity induced by a pharmacokinetic interaction with bupropion: A case report
by: Kelly N. Gable, PharmD, BCPP, et al.
Published: (2025-06-01)

Potential changes impacting psychiatric pharmacy by 2030
by: Amy Werremeyer, PharmD, BCPP, et al.
Published: (2025-02-01)

191 Pharmacist Empowerment, Mandatory 4T Scoring and Real-time EHR Alerts to Optimize Antithrombosis Stewardship Around Diagnosis and Management of Heparin Induced Thrombocytopenia: The Persistent Study
by: Shruti N. Karanth, PharmD, et al.
Published: (2025-05-01)

128 Evaluation of Heparin-Induced Thrombocytopenia Testing to Improve Anticoagulation Stewardship in an Acute Care Setting
by: Yelena Samofalova, PharmD, et al.
Published: (2025-05-01)

Outcomes Associated with Time in Therapeutic Range for Patients Receiving Intravenous Unfractionated Heparin
by: Mujtaba Mahmud PharmD, et al.
Published: (2025-08-01)

Childhood and Adolescents Sleep Bruxism Treatment: A Systematic Review
by: Jordana Senff, et al.
Published: (2023-09-01)

ELECTROENCEPHALOGRAPHIC FEATURES IN PATIENTS WITH BRUXISM
by: N. V. Yurieva, et al.
Published: (2016-05-01)

Evaluating the Efficacy and Safety of Direct Oral Anticoagulants Compared to Vitamin K Antagonists in Patients with Antiphospholipid Syndrome: Updated Systematic Review and Meta-Analysis
by: Lama Alfehaid PharmD, MME, et al.
Published: (2025-08-01)

Memantine leading to physical aggression in the treatment of chronic catatonia secondary to schizophrenia: A case report
by: Andrew Chantha Hean, PharmD, et al.
Published: (2025-08-01)

Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia
by: Abdulaali R. Almutairi PhD, et al.
Published: (2025-02-01)

Two Is Better Than One: Clinical Assessments
by: Ahlam A. Ayyad PharmD, et al.
Published: (2025-04-01)

Guanfacine for the management of the behavioral manifestations of delirium in older hospitalized adults
by: Kayla Garvey, PharmD, et al.
Published: (2025-06-01)

A Retrospective, Single-Center Assessment of Changes in Pain, Agitation, and Delirium Management Before and During the COVID-19 Pandemic
by: Rachel L. Winner, PharmD, BCCCP, et al.
Published: (2025-01-01)

Bruxism, Lifestyle, Anxiety, and Sleep Impairment in Dental Students
by: Priscila Brenner Hilgenberg-Sydney, et al.
Published: (2024-12-01)

Efficiency of Electromyographic Examination in Dental Patients with Signs of Bruxism to Determine the Functional State of the Muscles of the Maxillofacial Region
by: S. P. Rubnikovich, et al.
Published: (2025-02-01)

Bruxism triggered by Escitalopram persists even after discontinuing the drug: a case report
by: Gabriel Barbosa Resende, et al.
Published: (2024-12-01)

100 Comparison of Warfarin Time in Therapeutic Range Before and After Home Meter Enrollment
by: Kaitlyn P. Coggsdale, PharmD, CPP, et al.
Published: (2025-05-01)

Evaluating the efficacy of blister packaging in improving medication adherence within psychiatry: A systematic literature review
by: Eric P. Borrelli, PhD, PharmD, MBA, et al.
Published: (2025-06-01)

Comparison of Direct Oral Anticoagulants for Treatment of Cerebral Venous Thrombosis – A Retrospective Cohort Study
by: Paul Phan PharmD, et al.
Published: (2025-01-01)

The prevalence of bruxism and related factors in patients with multiple sclerosis: a comparative study
by: Faruk Ömer Odabas, et al.

A Rare Case of Buspirone-induced Dystonia
by: Priyanka Sahajwani, et al.
Published: (2024-10-01)

Lost Rate Control and Tachycardia-Induced Cardiomyopathy as a Result of an Interaction Between Enzalutamide and Diltiazem
by: Adrian de Boer, PharmD, et al.
Published: (2025-07-01)